Suchergebnisse - "Hao, Wendong"

PubPharm (7)

1

Increased inflammatory mediators levels are associated with clinical outcomes and prolonged illness in severe COVID-19 patients

enthalten in: International immunopharmacology | 2023

von Hao, W. | Liu, M. | Bai, C. | +3

2

Tanshinone IIA protects against chronic obstructive pulmonary disease via exosome‑shuttled miR‑486‑5p

enthalten in: International journal of molecular medicine | 2022

von Tian, D. | Miao, Y. | Hao, W. | +4

3

Increased chemokines levels in patients with chronic obstructive pulmonary disease : correlation with quantitative computed tomography metrics

enthalten in: The British journal of radiology | 2021

von Hao, W. | Li, M. | Pang, Y. | +2

4

Clinical features of atypical 2019 novel coronavirus pneumonia with an initially negative RT-PCR assay

enthalten in: The Journal of infection | 2020

von Hao, W. | Li, M.

CommentIn: J Infect. 2020 Jul;81(1):147-178. - PMID 32209381

5

Clinical diagnostic value of CT imaging in COVID-19 with multiple negative RT-PCR testing

enthalten in: Travel medicine and infectious disease | 2020

von Hao, W. | Li, M.

6

Increased levels of inflammatory biomarker CX3CL1 in patients with chronic obstructive pulmonary disease

enthalten in: Cytokine | 2020

von Hao, W. | Li, M. | Zhang, C. | +2

7

Severity of chronic obstructive pulmonary disease with 'exacerbator with emphysema phenotype' is associated with potential biomarkers

enthalten in: Postgraduate medical journal | 2020

von Hao, W. | Li, M. | Zhang, Y. | +2

1
[1]